Poncirin

Poncirin is the 7-O-neohesperidoside of isosakuranetin. Poncirin can be extracted from trifoliate orange (Poncirus trifoliata)

Poncirin is a flavanone glycoside found to be present in the Poncirus trifoliata and Citrus reticulate having bitter taste. Biological importance of poncirin for their anti-inflammatory activity through inhibition of PGE2 and IL-6 production has been investigated in the scientific field. Biological importance of poncirin against bacterial, viral infections, gastric disease and human gastric cancer has been investigated in the medicine. Pharmacological data analysis revealed the biological application of poncirin against bone loss, inflammation, colitis, human gastric cancer, gastritis, liver injury and alzheimer's disease. From the analysis of the presented scientific information of poncirin it was found that poncirin have significant biological activities and health benefit in the modern health sectors for the treatment of human health complications and could be used as a drug in the future.

Human Biological Effects

Poncirin (isosakuranetin-7-\(O\)-neohesperidoside) is a bitter flavonoid glycoside found abundantly in the fruits of various citrus species, most notably in Poncirus trifoliata (trifoliate orange) and certain traditional citrus cultivars. Preclinical pharmacological research involving human cell lines, ex vivo assays, and animal models highlights several distinct biological and therapeutic effects.

1. Anti-Inflammatory and Immunomodulatory Actions

• Suppression of Inflammatory Cascades: Poncirin exhibits strong anti-inflammatory properties by blocking the nuclear factor kappa B (NF-\(\kappa\)B) signaling pathway in immune cells (such as macrophages).
• Downregulation of Inflammatory Mediators: This inhibition leads to a marked reduction in the expression and release of key pro-inflammatory cytokines and enzymes, including TNF-\(\alpha\), IL-6, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2).

2. Metabolic Regulation and Antidiabetic Support

• Insulin Signaling and Glucose Uptake: In cellular models of insulin resistance, poncirin promotes glucose consumption and cellular uptake by activating the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway.
• Anti-Glycation Capacities: It demonstrates potential in mitigating long-term diabetic complications by suppressing advanced glycation end-products (AGEs).

3. Hepatoprotection and Lipid Metabolism

• Liver Injury Mitigation: Pharmacological studies indicate that poncirin protects against acute and chronic liver insults, such as alcoholic liver injury, by regulating hepatic lipid metabolism and lowering localized oxidative stress.
• Receptor-Mediated Pathways: These hepatoprotective effects are heavily mediated through the activation of peroxisome proliferator-activated receptor alpha (PPAR-\(\alpha\)) pathways.

4. Bone Health and Cellular Differentiation

• Promoting Osteoblastogenesis: Unlike many compounds that merely slow bone breakdown, poncirin actively enhances osteoblast differentiation by upregulating key transcription factors like Runx2 and increasing alkaline phosphatase (ALP) activity.
• Inhibiting Adipogenesis: Simultaneously, it suppresses adipocyte differentiation in mesenchymal stem cells by downregulating PPAR-\(\gamma\), pointing to a dual modulatory role in bone marrow microenvironments and osteoporosis models.

5. Cardiovascular and Ischemic Protection

• Oxidative Stress Reduction: In models of myocardial ischemia-reperfusion injury, poncirin helps preserve cardiac tissue viability, reduce infarct size, and suppress cellular apoptosis.
• Signaling Activation: These protective effects are tied to the upregulation of survival pathways, including the PI3K/Akt/PGC-\(1\alpha\) axis, which helps shield cardiac myocytes from severe oxidative damage.

Note: As with similar citrus glycosides, these insights are based on in vitro and animal investigations; comprehensive human clinical trial data confirming therapeutic dosages and clinical pharmacokinetics remain sparse.

ARTICLES/STUDIES

Cardiovascular

Poncirin ameliorates cardiac ischemia-reperfusion injury.

Colitis

Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance

COVID-19

Computational approaches to define poncirin from Magnolia champaka leaves as a novel multi-target inhibitor of SARS-CoV-2.

Neuroprotective

• Poncirin ameliorates oxygen glucose deprivation/reperfusion injury in cortical neurons.
• Poncirin suppresses lipopolysaccharide (LPS)-induced microglial inflammation and ameliorates brain ischemic injury.

Pain

Anti-hyperalgesic properties of a flavanone derivative Poncirin in acute and chronic inflammatory pain models in mice.